XBP1 and chronic rhinosinusitis without nasal polyps: Furthermore, depletion of XBP1 alleviated pathological changes of nasal mucosa and inflammatory biomarkers (both types 1 and 2) by repressing the HIF-1a expression and the Wnt/β-catenin pathway activation, indicating a possible underlying role in the pathogenesis of CRSsNP.